Incidence of axillary recurrence in 113 sentinel node negative breast cancer patients: A 3-year follow-up study

European Journal of Surgical Oncology

Volumn 31, Issue 3, 2005, Pages 221-225

  Kokke, M C ^a   Jannink, I ^a   Barneveld, P C ^a   van der Linden, J C ^a   Gelderman, W A H ^a   Wissing, J C ^a   Bosscha, K ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Axillary recurrence; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; HORMONE DERIVATIVE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; METASTASIS POTENTIAL; NEEDLE BIOPSY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODES; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; RECURRENCE; SENTINEL LYMPH NODE BIOPSY;

EID: 14944361270     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.11.013     Document Type: Article

References (31)

1. B. Fisher M. Bauer D.L. Wickerham C.K. Redmond E.R. Fisher A.B. Cruz et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update Cancer 52 1983 1551-1557
2. C.L. Carter C. Allen D.E. Henson Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases Cancer 63 1989 181-187
3. A.E. Giuliano D.M. Kirgan J.M. Guenther D.L. Morton Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 1994 391-398
4. J.J. Albertini G.H. Lyman C. Cox T. Yeatman L. Balducci N. Ku et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer JAMA 11 1996 1818-1822
5. O.E. Nieweg E.J. Rutgers L. Jansen R.A. Valdes Olmos J.L. Peterse K.A. Hoefnagel et al. Is lymphatic mapping in breast cancer adequate and safe? World J Surg 25 2001 780-788
6. D. Krag D. Weaver T. Ashikaga F. Moffat V.S. Klimberg C. Shriver et al. The sentinel node in breast cancer - a multicenter validation study N Engl J Med 339 1998 941-946
7. R.R. Turner D.W. Ollila D.L. Krasne A.E. Giuliano Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma Ann Surg 226 1997 271-276
8. M.W. Kissin G. Querci della Rovere D. Easton G. Westbury Risk of lymphoedema following the treatment of breast cancer Br J Surg 73 1986 580-584
9. M.F. Ernst A.C. Voogd W. Balder J.H. Klinkenbijl J.A. Roukema Early and late morbidity associated with axillary levels I-III dissection in breast cancer J Surg Oncol 79 2002 151-155
10. P. Schrenk R. Rieger A. Shamiyeh W. Wayand Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma Cancer 88 2000 608-614
11. M. Golshan W.J. Martin K. Dowlatshahi Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection Am Surg 69 2003 209-211
12. F. Peintinger R. Reitsamer H. Stranzl G. Ralph Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients Br J Cancer 89 2003 648-652
13. T. Kim O. Agboola G.H. Lyman Lymphatic mapping and sentinel lymph node sampling in breast cancer: A metanalysis ASCO 139 2002 [abstract]
14. U. Veronesi G. Paganelli V. Galimberti G. Viale S. Zurrida M. Bedoni et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet 349 1997 1864-1867
15. C. De Cicco M. Cremonesi A. Luini M. Bartolomei C. Grana G. Prisco et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer J Nucl Med 39 1998 2080-2084
16. R.M. Roumen G.P. Kuijt I.H. Liem M.W. van Beek Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection Br J Surg 88 2001 1639-1643
17. G. Singh Ranger K. Mokbel The evolving role of sentinel node biopsy for breast cancer Eur J Surg Oncol 29 2003 423-425
18. P.J. Borgstein R. Pijpers E.F. Comans P.J. van Diest R.P. Boom S. Meijer Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection J Am Coll Surg 186 1998 275-283
19. S. Meijer H. Torrenga J.R. van der Sijp Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases Ned Tijdschr Geneeskd 146 2002 942-946
20. P.I. Haigh N.M. Hansen K. Qi A.E. Giuliano Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer Ann Surg Oncol 7 2000 21-27
21. E. Vendrell-Torne J. Setoain-Quinquer F.M. Domenech-Torne Study of normal mammary lymphatic drainage using radioactive isotopes J Nucl Med 13 1972 801-805
22. R.T. Turner-Warwick The lymphatics of the breast Br J Surg 46 1959 574-582
23. P.J. Tanis O.E. Nieweg R.A. Valdes Olmos B.B.R. Kroon Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy J Am Coll Surg 192 2001 399-409
24. B. Cady M.D. Stone J.G. Schuler R. Thakur M.A. Wanner P.T. Lavin The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening Arch Surg 131 1996 301-308
25. P. Schrenk M. Hatzl-Griesenhofer A. Shamiyeh W. Waynad Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection J Surg Oncol 77 2001 165-170
26. A.E. Giuliano P.I. Haigh M.B. Brennan N.M. Hansen M.C. Kelley W. Ye et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer J Clin Oncol 18 2000 2553-2559. Erratum in: J Clin Oncol 2000; 18: 3877
27. U. Veronesi V. Galimberti S. Zurrida F. Pigatto P. Veronesi C. Robertson et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer Eur J Cancer 37 2001 454-458
28. M.A. Chung M.M. Steinhoff B. Cady Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy Am J Surg 184 2002 310-314
29. R. Reitsamer F. Peintinger E. Prokop C. Menzel W. Cimpoca L. Rettenbacher Sentinel lymph node biopsy alone without axillary lymph node dissection-follow up of sentinel lymph node negative breast cancer patients Eur J Surg Oncol 29 2003 221-223
30. U. Veronesi G. Paganelli G. Viale A. Luini S. Zurrida V. Galimberti et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 2003 546-553
31. A.M. Naik J. Fey M. Gemignani A. Heerdt L. Montgomery J. Petrek et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures Ann Surg 240 2004 462-468